SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-13-021332
Filing Date
2013-04-11
Accepted
2013-04-11 16:06:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 v340743_424b3.htm 424B3 3662915
  Complete submission text file 0001144204-13-021332.txt   3663912
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 424B3 | Act: 33 | File No.: 333-187656 | Film No.: 13756340
SIC: 2834 Pharmaceutical Preparations